Regulation of human coagulation factor X gene expression by GATA-4 and theSp family of transcription factors

Citation
Hl. Hung et al., Regulation of human coagulation factor X gene expression by GATA-4 and theSp family of transcription factors, BLOOD, 97(4), 2001, pp. 946-951
Citations number
22
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
97
Issue
4
Year of publication
2001
Pages
946 - 951
Database
ISI
SICI code
0006-4971(20010215)97:4<946:ROHCFX>2.0.ZU;2-G
Abstract
Serine protease factor Xa plays a critical role in the coagulation cascade, Zymogen factor X is synthesized and modified in the liver. To understand t he mechanisms governing the liver-specific expression of factor X, the prox imal promoter of human factor X was previously characterized. Two crucial c is elements at -73 and -128 and their cognate binding proteins, HNF-4 and N F-Y, respectively, were identified. In this report, studies are extended to 3 additional cis elements within the factor X promoter. Using gel mobility shift assays, the liver-enriched protein GATA-4 was identified as the prot ein binding to the GATA element at -96, GATA-4 transactivates the factor X promoter 28-fold in transient transfection experiments. It was also determi ned that the Sp family of transcription factors binds 2 DNase I-footprinted sites at -165 and -195, Disruption of Sp protein binding at either site re duces the promoter activity by half, Simultaneous disruption of both sites reduces the promoter activity 8-fold. This is the first report indicating t he involvement of GATA-4 in the regulation of clotting factor expression. T hese observations provide novel insight into mechanisms by which the vitami n K-dependent coagulation factors are regulated. (C) 2001 by The American S ociety of Hematology.